UBS Group’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $188 | Sell |
|
|||||
|
2025
Q1 | $9.96K | Sell |
|
|||||
|
2024
Q4 | $99.7K | Buy |
|
|||||
|
2024
Q3 | $308 | Sell |
|
|||||
|
2024
Q2 | $4.45K | Sell |
|
|||||
|
2024
Q1 | $64.5K | Buy |
|
|||||
|
2023
Q4 | $46.6K | Buy |
|
|||||
|
2023
Q3 | $40.6K | Sell |
|
|||||
|
2023
Q2 | $91.4K | Sell |
|
|||||
|
2023
Q1 | $305K | Sell |
|
|||||
|
2022
Q4 | $1.59M | Buy |
|
|||||
|
2022
Q3 | $212K | Buy |
|
|||||
|
2022
Q2 | $21K | Sell |
|
|||||
|
2022
Q1 | $2.71M | Buy |
|
|||||
|
2021
Q4 | $1.64M | Buy |
|
|||||
|
2021
Q3 | $167K | Sell |
|
|||||
|
2021
Q2 | $361K | Buy |
|
|||||
|
2021
Q1 | $30K | Sell |
|
|||||
|
2020
Q4 | $31K | Buy |
|
|||||
|
2020
Q3 | $18K | Sell |
|
|||||
|
2020
Q2 | $41K | Sell |
|
|||||
|
2020
Q1 | $79K | Sell |
|
|||||
|
2019
Q4 | $77K | Buy |
|
|||||
|
2019
Q3 | $58K | Buy |
|
|||||
|
2019
Q2 | $25K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $45K | Buy |
|
|||||
|
2018
Q3 | $40K | Buy |
|